The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram

BACKGROUND: Citalopram is the most commonly prescribed antidepressant in Canada. Concerns have been raised about its cardiac safety, and a dose-dependent prolongation of the QT interval has been documented. Drug interactions involving concomitant use of other medications that prolong the QT interval...

Descripción completa

Detalles Bibliográficos
Autores principales: Friesen, Kevin J, Bugden, Shawn C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547663/
https://www.ncbi.nlm.nih.gov/pubmed/26316822
http://dx.doi.org/10.2147/DHPS.S91046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547663/
https://www.ncbi.nlm.nih.gov/pubmed/26316822
http://dx.doi.org/10.2147/DHPS.S91046

Ejemplares similares